Evolving Role of
Immunotherapy
in Cancer Treatment

Christine M. Walko, Pharm.D., BCOP, FCCP, Activity Chair
Associate Member, Department of Individualized Cancer Management
Moffitt Cancer Center
Tampa, Florida

Christine M. Walko, Pharm.D., BCOP, FCCP, is a Personalized Medicine Specialist at the DeBartolo Family Personalized Medicine Institute at the H. Lee Moffitt Cancer Center and is also Associate Professor at the University of South Florida Morsani College of Medicine in Tampa, Florida. She is also the Chair of the Clinical Genomics Action Committee (CGAC) and attending on the Personalized Medicine Clinical Service at H. Lee Moffitt Cancer Center. Dr. Walko received her Doctor of Pharmacy from Duquesne University in Pittsburgh. She completed a pharmacy practice residency at Virginia Commonwealth University Health System/Medical College of Virginia Hospitals in Richmond, Virginia. She also completed a Hematology/Oncology specialty residency at the University of North Carolina (UNC) Hospitals and Clinics and a Hematology/Oncology fellowship at the University of North Carolina School of Pharmacy in Chapel Hill, North Carolina. She is a board certified oncology pharmacist.

She has researched and published extensively in oncology therapy and has presented nationally and internationally on oncology and pharmacogenomics and other topics related to treating patients with cancer.

Ragini R. Kudchadkar, M.D.
Associate Professor
Winship Cancer Institute of Emory University
Associate Director Hematology/Oncology Fellowship Program
Atlanta, Georgia

Ragini R. Kudchadkar, M.D., is Associate Professor of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University in Atlanta, Georgia. She also serves as Associate Director of the Hematology/Oncology Fellowship Program.                         

Dr. Kudchadkar completed her Bachelor of Science degree in Neuroscience and Behavioral Biology and her Doctor of Medicine degree from Emory University. After completing her Internal Medicine residency at Emory University she completed her Hematology and Medical Oncology Fellowship at the University of Colorado Health Sciences Center in Denver, Colorado.

Dr. Kudchadkar is a cutaneous oncologist specializing in drug development and clinical trials primarily for melanoma. Her other interests include how current melanoma therapies affect the natural immune function both in T-cells and B-cells. She is also interested in exploring new treatments for rare cutaneous disease such as advanced basal cell carcinoma, merkel cell carcinoma, and squamous cell carcinoma.

Dr. Kudchadkar is a member of the American Society of Clinical Oncology, the Society for Melanoma Research, and the American Association for Cancer Research. She has served on the National Comprehensive Cancer Network Melanoma guidelines committee. She has authored numerous book chapters, review articles, and peer-reviewed papers as well as presented nationally in melanoma and immunotherapy.